An attempt to patent a medicine already patented in the U.S. and elsewhere, and currently being developed by U.S. drugmaker Gilead Sciences, raises serious intellectual
Tag: Gilead Sciences
Jury awards Merck $200M in patent damages, 10% of what it had sought
A California jury has awarded pharmaceutical drug company Merck $200 million, a fraction of what it had sought, for infringement of two of its patents
Validated Merck patents could mean a $3B+ windfall, after appeals
While many high-tech patents are suffering from devaluation the value of some pharmaceutical patents is soaring. Merck & Co. won a legal victory over
